trending Market Intelligence /marketintelligence/en/news-insights/trending/bCU4RqQCZEUTU67acTHLRQ2 content esgSubNav
In This List

Mylan launches generic version of EpiPen

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Mylan launches generic version of EpiPen

Mylan NV launched an authorized generic for its EpiPen Auto-Injector at $300 for a pack of two injections.

The generic product has the same drug formulation and device functionality as EpiPen and will reach retail pharmacies in the week of Dec. 19.